Strategic Focus Target early to mid-stage tech companies in life sciences with emphasis on computational biology, chemistry, digitization of medicine, digital therapies, and cutting-edge drug development to align with your portfolio and potential co-investment opportunities.

Industry Expertise Leverage Partners' domain experience across healthcare, finance, and intellectual property to position Scientia Ventures as a strategic value-add partner for startups seeking guidance on regulatory pathways, IP strategy, and scaling operations.

Small but Targeted Operate with a lean team (2-10 employees) yet pursue high-impact investments, suggesting a need for scalable outsized support from external resources, consultants, and ecosystem partners to accelerate portfolio growth.

Funding Readiness With reported revenue in the range of one to ten million, identify opportunities to engage in follow-on rounds, syndication with larger VC firms, and strategic collaborations that align with scalable clinical and translational milestones.

Competitive Benchmarking Position against larger life sciences investors by highlighting hands-on operational support, founder-first mentorship, and a proven track record of healthcare outcomes to attract high-potential teams seeking practical, value-driven capital.